Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

72.29
+4.246.23%
Post-market: 72.07-0.2200-0.30%18:52 EST
Volume:3.11M
Turnover:223.37M
Market Cap:13.93B
PE:-17.28
High:72.98
Open:67.84
Low:67.82
Close:68.05
52wk High:81.33
52wk Low:28.33
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.81
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.21
PE(LYR):-25.11

Loading ...

BridgeBio Pharma (BBIO) Gets a Buy from Evercore ISI

TIPRANKS
·
Feb 06

Piper Sandler Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
Feb 06

BridgeBio Pharma Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Barclays Initiates Coverage on BridgeBio Pharma With Overweight Rating, $157 Price Target

MT Newswires Live
·
Jan 28

BridgeBio Pharma Grants Equity Awards to 12 New Employees Under Amended Inducement Plan

Reuters
·
Jan 28

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 28

BridgeBio Pharma Inc - Receives $619.3 Mln Net Proceeds From Note Offering - SEC Filing

THOMSON REUTERS
·
Jan 22

BridgeBio Pharma Announces $550 Million Convertible Senior Notes Offering

Reuters
·
Jan 22

BridgeBio Pharma Inc : JP Morgan Raises Target Price to $89.00 From $77.00

THOMSON REUTERS
·
Jan 21

BUZZ-U.S. STOCKS ON THE MOVE -Analog Devices, BridgeBio, TransDigm

Reuters
·
Jan 16

BUZZ-BridgeBio rises after $550 mln convertible debt offering

Reuters
·
Jan 16

BridgeBio Prices $550 Million Convertible Senior Notes Offering

MT Newswires Live
·
Jan 16

BridgeBio Prices Offering of $550 Million Convertible Senior Notes Due 2033 to Prefund Repayment of Convertible Senior Notes Due 2027

THOMSON REUTERS
·
Jan 16

BUZZ-BridgeBio dips after unveiling $550 mln convertible bond deal

Reuters
·
Jan 15

BRIEF-Bridgebio Continues Long Term Debt Management Strategy And Announces Proposed Offering Of Convertible Senior Notes

Reuters
·
Jan 15

BridgeBio Pharma Announces $550 Million Convertible Senior Notes Offering

Reuters
·
Jan 15

BridgeBio Pharma Inc - Proceeds to Repurchase or Repay 2027 Notes

THOMSON REUTERS
·
Jan 15

BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes Due 2033 to Prefund Repayment of Convertible Senior Notes Due 2027

THOMSON REUTERS
·
Jan 15

BridgeBio Oncology Therapeutics Grants Inducement Stock Options Under 2025 Plan

Reuters
·
Jan 14

Evercore ISI Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Jan 13